✦ LIBER ✦

Basiliximab with delayed introduction of calcineurin inhibitors as a renal-sparing protocol following liver transplantation in children with renal impairment

✍ Scribed by Mouzaki, M.; Yap, J.; Avinashi, V.; Babu, A.; Fu, A.; Deangelis, M.; Van Roestel, K.; Ghanekar, A.; Kamath, B.; Avitzur, Y.; Fecteau, A.; Jones, N.; Ling, S.; Grant, D.; Ng, V.

Book ID: 121679552
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 92 KB
Volume: 17
Category: Article
ISSN: 1397-3142
DOI: 10.1111/petr.12158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Following-up of a Four-Dose Daclizumab I

Following-up of a Four-Dose Daclizumab Induction Therapy Without Calcineurin Inhibitors in a Liver Transplantation Recipient With Severe Renal Dysfunction: A Case Report

✍ Y. Zhang; T. Wen; L. Yan; Z. Chen; B. Li; Y. Zeng 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 107 KB

A randomized controlled trial of late co

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin